813 related articles for article (PubMed ID: 27094609)
1. Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines.
Phipps E; Prasanna D; Brima W; Jim B
Clin J Am Soc Nephrol; 2016 Jun; 11(6):1102-1113. PubMed ID: 27094609
[TBL] [Abstract][Full Text] [Related]
2. Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications.
Jim B; Karumanchi SA
Semin Nephrol; 2017 Jul; 37(4):386-397. PubMed ID: 28711078
[TBL] [Abstract][Full Text] [Related]
3. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
[TBL] [Abstract][Full Text] [Related]
5. Preeclampsia and eclampsia: the conceptual evolution of a syndrome.
Erez O; Romero R; Jung E; Chaemsaithong P; Bosco M; Suksai M; Gallo DM; Gotsch F
Am J Obstet Gynecol; 2022 Feb; 226(2S):S786-S803. PubMed ID: 35177220
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy.
Aggarwal S; Sunderland N; Thornton C; Xu B; Hennessy A; Makris A
Am J Obstet Gynecol; 2017 Feb; 216(2):170.e1-170.e8. PubMed ID: 27793555
[TBL] [Abstract][Full Text] [Related]
7. Endothelin: key mediator of hypertension in preeclampsia.
George EM; Granger JP
Am J Hypertens; 2011 Sep; 24(9):964-9. PubMed ID: 21677700
[TBL] [Abstract][Full Text] [Related]
8. Evidence-Based Revised View of the Pathophysiology of Preeclampsia.
Ahmed A; Rezai H; Broadway-Stringer S
Adv Exp Med Biol; 2017; 956():355-374. PubMed ID: 27873232
[TBL] [Abstract][Full Text] [Related]
9. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic Imbalance as a Contributor of Preeclampsia.
Dymara-Konopka W; Laskowska M; Błażewicz A
Curr Pharm Biotechnol; 2018; 19(10):797-815. PubMed ID: 30255753
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension.
Herse F; LaMarca B
Am J Reprod Immunol; 2013 Apr; 69(4):413-8. PubMed ID: 23279165
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of preeclampsia.
Mutter WP; Karumanchi SA
Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
[TBL] [Abstract][Full Text] [Related]
14. Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy.
Hauspurg A; Jeyabalan A
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1211-S1221. PubMed ID: 35177218
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond.
Xia Y; Kellems RE
Circ Res; 2013 Jun; 113(1):78-87. PubMed ID: 23788505
[TBL] [Abstract][Full Text] [Related]
16. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
Tarca AL; Taran A; Romero R; Jung E; Paredes C; Bhatti G; Ghita C; Chaiworapongsa T; Than NG; Hsu CD
Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477
[TBL] [Abstract][Full Text] [Related]
17. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis.
Tal R
Biol Reprod; 2012 Jun; 87(6):134. PubMed ID: 23034156
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic Factors and Long-Term Cardiovascular Risk in Women That Developed Preeclampsia During Pregnancy.
Garrido-Gimenez C; Mendoza M; Cruz-Lemini M; Galian-Gay L; Sanchez-Garcia O; Granato C; Rodriguez-Sureda V; Rodriguez-Palomares J; Carreras-Moratonas E; Cabero-Roura L; Llurba E; Alijotas-Reig J
Hypertension; 2020 Dec; 76(6):1808-1816. PubMed ID: 33012203
[TBL] [Abstract][Full Text] [Related]
20. The role of endoglin and its soluble form in pathogenesis of preeclampsia.
Margioula-Siarkou G; Margioula-Siarkou C; Petousis S; Margaritis K; Vavoulidis E; Gullo G; Alexandratou M; Dinas K; Sotiriadis A; Mavromatidis G
Mol Cell Biochem; 2022 Feb; 477(2):479-491. PubMed ID: 34783962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
